Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. - Wikidata - wikimedia - TriplyDB

Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database.

Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database.

http://www.wikidata.org/entity/Q46724302

about

LocDB: experimental annotations of localization for Homo sapiens and Arabidopsis thaliana A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.Human body fluid proteome analysis.Liquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation.Investigation of an albumin-enriched fraction of human serum and its albuminome.Intact-protein analysis system for discovery of serum-based disease biomarkers.Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.Temporal profiling of the secretome during adipogenesis in humans Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Identification of serum CCL15 in hepatocellular carcinoma.Parallel proteomics to improve coverage and confidence in the partially annotated Oryctolagus cuniculus mitochondrial proteome.The utilization of Triton X-100 for enhanced two-dimensional liquid-phase proteomics.Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications High dynamic range characterization of the trauma patient plasma proteome Comprehensive analysis of protein modifications by top-down mass spectrometry The Salivary Protein Repertoire of the Polyphagous Spider Mite Tetranychus urticae: A Quest for Effectors.Overview: the maturing of proteomics in cardiovascular research.Proteomics and heart disease: identifying biomarkers of clinical utility.Immunoproteomics Identification of Major IgE and IgG4 Reactive Schistosoma japonicum Adult Worm Antigens Using Chronically Infected Human Plasma.Perspectives of proteomics in acute myeloid leukemia.A proteomic primer for the clinician Proteomic technologies in the study of kinases: novel tools for the investigation of PKC in the heart.Multidimensional protein fractionation using ProteomeLab PF 2D for profiling amyotrophic lateral sclerosis immunity: A preliminary report.Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.Biomarker discovery: proteome fractionation and separation in biological samples.Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2D liquid separations, protein microarrays and tandem mass spectrometry.Comparative LC-MS: a landscape of peaks and valleys.Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis.Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.Methodology and applications of disease biomarker identification in human serum.Divide and conquer: the application of organelle proteomics to heart failure.Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples.Achievements and perspectives of top-down proteomics.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types.Identification of specific nuclear structural protein alterations in human breast cancer.Three dimensional liquid chromatography coupling ion exchange chromatography/hydrophobic interaction chromatography/reverse phase chromatography for effective protein separation in top-down proteomics.Relative quantitation of proteins fractionated by the ProteomeLab PF 2D system using isobaric tags for relative and absolute quantitation (iTRAQ).A method developed to fractionate intact proteins based on capillary electrophoresis.

P2860

Q24608535-B447B093-98AD-49DE-8389-D9E848404D56 Q30830185-D9FC97F5-38B0-4F48-A57B-6A9979EF9E20 Q33262623-7155A7ED-936B-4863-B998-1DED3097FA18 Q33457379-0F64D723-6E3C-4C3C-8292-61FE9717D2F6 Q33701508-EEB69019-6CCA-42CA-86BA-7B5F4C0F0A70 Q33863832-4059FDAB-E0DC-46C3-85F2-C791170BE6B3 Q33882818-DAF7BE85-7FF2-4893-9734-46235732957C Q34167823-BC60C8D6-5E57-4811-82CA-A4D799272973 Q34250328-82C79296-FBC7-4EF5-A11D-84830BEB83D2 Q34549009-23F1496F-AAA8-4228-810A-B250981F0799 Q34551857-146ED23C-C647-42F0-9BB8-E78B86CDCA29 Q35380367-3782E0FE-913D-4A12-8F82-805DAB9B8CC5 Q35610017-69459352-12D4-4FE9-AFEC-64927985CC52 Q35613820-A3D7D5B6-66CB-4F96-B3F9-805E1B75EF7B Q35873932-EEA720B7-109B-4BDF-B9D4-747D9B2A9790 Q36153047-3EEFBF46-D615-47A9-96DF-36D0B4103EDE Q36406428-E20BAB75-4BE5-4D19-B751-B3022CCC2444 Q36445586-08C9A1CA-6085-4A79-8914-4A9EE3B4EF0C Q36463308-A0E1BF4D-A99F-4E3E-9EAD-7B1AC927EC91 Q36668271-4E3AF25D-10E0-4C36-B0E3-712ADC23B9AB Q36698789-116BCDF2-8374-43BC-A899-172E449D0C31 Q36840300-0B567F45-7FCC-48C6-89C9-C0452FC0F983 Q36891325-E931F67B-845F-4116-B362-9061E327C16F Q36919986-C4009469-5639-4DEE-BA61-7211519413E7 Q37046315-E54D7C2E-939C-4C5A-B64D-438A9FE0C2D5 Q37076892-26B6E37B-6071-4E15-BD89-C2C786AD638A Q37079448-C65A1631-30AB-46A6-B4E0-A22DF42EA6DB Q37093728-9741EA3A-0B28-416D-BE06-B56D5E2EFE4E Q37257661-301AE244-3056-4762-931F-7954ECA4E275 Q37447351-F38E7E58-C1CF-44F6-89C9-712E729E28F9 Q37574961-78027E77-0520-4D6A-AEF2-74FF29BAD988 Q37605842-3D194FFC-991D-481F-9866-8F6D46578CC9 Q37756771-917D6EFB-5A17-4B90-A58C-CC990620E52E Q37791081-603C8BE5-F139-44E4-9DB4-963E1568D45B Q38552059-0B7C47EC-9AF4-420D-87E5-413204B37229 Q39190259-304671CD-0F48-4BCB-BE96-B0E0F88A5FCF Q39512052-E20BBEA5-8290-485C-9150-350594BD4797 Q41082825-6434FDDB-7491-454C-A7BE-26EB53B6E294 Q50925518-41D8FD66-C9DF-4BC6-A28E-DDB2AF400AFE Q53653757-58C98F98-EA2C-4BCA-9F2C-9E96DBF42E46

P2860

Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database.

http://www.wikidata.org/entity/Q46724302

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Multidimensional liquid chroma ...... mization and protein database.

@en

Multidimensional liquid chroma ...... mization and protein database.

@nl

type

label

Multidimensional liquid chroma ...... mization and protein database.

@en

Multidimensional liquid chroma ...... mization and protein database.

@nl

prefLabel

Multidimensional liquid chroma ...... mization and protein database.

@en

Multidimensional liquid chroma ...... mization and protein database.

@nl

P1433

Q46724302-3DAB7114-4869-4985-886E-8778DABDCD18

P1476

Q46724302-5A65ADB3-9233-47F6-8A08-5B9B6241DE06

P2093

Q46724302-8ED0598D-03FE-44F4-9A4A-4D94D26128E6

Q46724302-DB44477A-B4FB-4FA8-BBA6-9EC5499B3C2B

Q46724302-F5576330-88F2-4F6D-8A73-F245AFDEE06F

P2860

Q46724302-0690E923-CCFB-4CAA-9B6C-3727EE309400

Q46724302-72D487C0-4AFC-42A2-AB8B-87413C19B536

Q46724302-89A5C2D4-D8CC-4B6D-A975-3881EE8EE152

Q46724302-93505AA1-E326-4A13-8BEF-3A9AC68185E2

Q46724302-A88968BB-6601-4904-9B8B-65C61DCD3761

Q46724302-B7D3BED8-B18D-4BAE-89F8-31FE3979393E

Q46724302-BB9A106E-1599-4488-9A3A-BD75B6A4A6C5

Q46724302-BF89FBE2-5340-4591-A0FA-965E8FCA51ED

Q46724302-C13E38DD-79A1-4933-8237-B784A613A9FB

Q46724302-C20D5FAB-D6C9-4DDB-B972-A6D4E14556B6

P304

Q46724302-E958E1A9-D26E-4076-A5DE-988F75EDD33E

P31

Q46724302-4645BAFF-91C5-4E41-B814-5FA4A09C473C

P356

Q46724302-E465B923-0E35-4BB7-B3B8-5051995EDCBA

P433

Q46724302-35C2D984-E5E4-4759-A1C0-AAEA7708597D

P478

Q46724302-160E6983-2BD0-40AB-ABA8-17E7304AC9E3

P577

Q46724302-C645F73C-2229-443C-B058-36D6DBC520F5

P698

Q46724302-C524F15D-EB5D-4248-9F96-ABE129B01858

P356

MCP.T500019-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Multidimensional liquid chroma ...... mization and protein database.

@en

P2093

Dawn Chen

http://www.w3.org/2001/XMLSchema#string

Jennifer E Van Eyk

http://www.w3.org/2001/XMLSchema#string

Simon Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

The human plasma proteome: a nonredundant list developed by combination of four separate sources

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry

Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: a pilot study

Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2+-dependent regulation of muscle contraction

The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.

Characterization of the low molecular weight human serum proteome.

Release of muscle proteins after downhill running in male and female subjects.

Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification.

Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry.

Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma.

P304

26-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.T500019-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16188874

http://www.w3.org/2001/XMLSchema#string